Prognostic value of modified Glasgow prognostic score in recurrent high-grade glial tumors treated with systemic treatment


Alan O., Telli T., Basoğlu T., Arikan R., Demircan N., Ercelep O., ...Daha Fazla

CLINICAL NEUROLOGY AND NEUROSURGERY, cilt.196, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Objectives: Malignant high-grade gliomas are the most common and aggressive type of primary brain tumor. We aimed to evaluate the prognostic value of modified Glasgow Prognostic Score (mGPS), which is combination of C-reactive protein (CRP) and albumin, in recurrent high-grade glioma patients treated with systemic treatment.